Linda Nolan, 65, passed away after a 20-year breast cancer battle. She was first diagnosed with stage-three breast cancer in 2005.

An international team of researchers led by the University of California San Diego has developed a new strategy to enhance ...

OCALA, Fla., Jan. 15, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) ("AIM” or the "Company”) today ...

We are thrilled to welcome Matt to Verastem Oncology at an important time as we prepare for a mid-2025 product launch and the transition into a commercial-stage company, while we continue to advance ...